Zolazepam

Basic Information

Item Value
DrugBank ID DB11555
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 70

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 insomnia (disease) KG + DL
2 neurocirculatory asthenia KG + DL
3 sleep disorder, initiating and maintaining sleep KG + DL
4 anxiety KG + DL
5 irritable bowel syndrome KG + DL
6 anxiety disorder KG + DL
7 agoraphobia KG + DL
8 benign paroxysmal torticollis of infancy KG + DL
9 juvenile onset Parkinson disease 19A KG + DL
10 dysthymic disorder KG + DL
11 enterocolitis (disease) KG + DL
12 acute encephalopathy with biphasic seizures and late reduced diffusion KG + DL
13 autonomic nervous system disease KG + DL
14 atypical juvenile parkinsonism KG + DL
15 mesial temporal lobe epilepsy with hippocampal sclerosis KG + DL
16 early myoclonic encephalopathy KG + DL
17 myoclonus, familial KG + DL
18 manic bipolar affective disorder KG + DL
19 hereditary late onset Parkinson disease KG + DL
20 major affective disorder KG + DL
21 acute intermittent porphyria KG + DL
22 inherited prion disease KG + DL
23 mitochondrial membrane transport disorder KG + DL
24 channelopathy-associated congenital insensitivity to pain, autosomal recessive KG + DL
25 alcohol withdrawal delirium KG + DL
26 dysautonomia KG + DL
27 nephrogenic syndrome of inappropriate antidiuresis KG + DL
28 vitamin B12-responsive methylmalonic acidemia KG + DL
29 bipolar disorder KG + DL
30 barbiturate abuse KG + DL
31 hallucinogen abuse KG + DL
32 antidepressant type abuse KG + DL
33 myofascial pain syndrome KG + DL
34 neurotic disorder KG + DL
35 alcohol withdrawal KG + DL
36 idiopathic granulomatous myositis KG + DL
37 myositis fibrosa KG + DL
38 common cold KG + DL
39 postpartum depression KG + DL
40 inclusion body myositis KG + DL
41 parkinsonian-pyramidal syndrome KG + DL
42 tendinitis KG + DL
43 Keppen-Lubinsky syndrome KG + DL
44 myelitis KG + DL
45 osteoarthritis KG + DL
46 Wernicke-Korsakoff syndrome KG + DL
47 auditory neuropathy KG + DL
48 autosomal dominant slowed nerve conduction velocity KG + DL
49 neurotic depression KG + DL
50 headache disorder KG + DL

(Showing top 50 of 70 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.